These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16434607)

  • 1. Igf-I genetic variation and breast cancer: the multiethnic cohort.
    Setiawan VW; Cheng I; Stram DO; Penney KL; Le Marchand L; Altshuler D; Kolonel LN; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):172-4. PubMed ID: 16434607
    [No Abstract]   [Full Text] [Related]  

  • 2. A systematic assessment of common genetic variation in CYP11A and risk of breast cancer.
    Setiawan VW; Cheng I; Stram DO; Giorgi E; Pike MC; Van Den Berg D; Pooler L; Burtt NP; Le Marchand L; Altshuler D; Hirschhorn J; Henderson BE; Haiman CA
    Cancer Res; 2006 Dec; 66(24):12019-25. PubMed ID: 17178901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
    Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
    Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
    Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
    Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
    Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXP3 germline polymorphisms are not associated with risk of breast cancer.
    Raskin L; Rennert G; Gruber SB
    Cancer Genet Cytogenet; 2009 Apr; 190(1):40-2. PubMed ID: 19264232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density.
    Verheus M; McKay JD; Kaaks R; Canzian F; Biessy C; Johansson M; Grobbee DE; Peeters PH; van Gils CH
    Breast Cancer Res Treat; 2008 Nov; 112(1):109-22. PubMed ID: 18064566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common genetic variation in calpain-10 gene (CAPN10) and diabetes risk in a multi-ethnic cohort of American postmenopausal women.
    Song Y; You NC; Hsu YH; Sul J; Wang L; Tinker L; Eaton CB; Liu S
    Hum Mol Genet; 2007 Dec; 16(23):2960-71. PubMed ID: 17855447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development.
    Wagner K; Hemminki K; Försti A
    Breast Cancer Res Treat; 2007 Sep; 104(3):233-48. PubMed ID: 17082888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.
    Johansson M; McKay JD; Wiklund F; Rinaldi S; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1644-50. PubMed ID: 19423539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk.
    Fehringer G; Boyd NF; Knight JA; Paterson AD; Dite GS; Giles GG; Southey MC; Andrulis IL; Hopper JL; Ozcelik H
    Breast Cancer Res Treat; 2009 Nov; 118(2):415-24. PubMed ID: 19229608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
    Diorio C; Brisson J; Bérubé S; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
    Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
    Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential clinical applications of insulin-like growth factor-1 ligand in human breast cancer.
    Chong YM; Subramanian A; Sharma AK; Mokbel K
    Anticancer Res; 2007; 27(3B):1617-24. PubMed ID: 17595785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is mitochondrial DNA variation associated with sporadic breast cancer risk?
    Mosquera-Miguel A; Alvarez-Iglesias V; Carracedo A; Salas A; Vega A; Carracedo A; Milne R; de León AC; Benitez J; Carracedo A; Salas A
    Cancer Res; 2008 Jan; 68(2):623-5; author reply 624. PubMed ID: 18199560
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study.
    Borugian MJ; Spinelli JJ; Sun Z; Kolonel LN; Oakley-Girvan I; Pollak MD; Whittemore AS; Wu AH; Gallagher RP
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):252-4. PubMed ID: 18199733
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
    Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of single nucleotide polymorphisms and haplotypes in BRCA1 in breast cancer: Czech case-control study.
    Soucek P; Borovanova T; Pohlreich P; Kleibl Z; Novotny J
    Breast Cancer Res Treat; 2007 Jun; 103(2):219-24. PubMed ID: 17039264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.